INTRODUCTION
The Internet is a common source for health information. Widespread adoption of the Internet has steadily increased over the past decade, with 84% of all American adults using the Internet in 2015. 1 Approximately 4.5% of all Internet searches are health-related, corresponding to 6.75 million health-related searches occurring daily in Google® alone. 2 The Internet is an attractive resource to patients, as it provides immediate and easily available information on virtually all health-related topics. Despite these advantages, there are concerns regarding the accuracy and reliability of online health information, and there is significant potential for patients to be misinformed. 3, 4 In addition, many online resources are written at a high reading level, which negatively impacts patient understanding, compliance, and overall health. 5 Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown etiology that is characterized by progressive dyspnea, worsening lung function, and poor prognosis. 6 Consensus guidelines on the diagnosis and management of IPF were published in 2011, 6 and were updated in 2015 based on new evidence regarding IPF pharmacotherapies. 7 Despite the existence of these widely read and highly cited guidelines, IPF patients are frequently misinformed by incorrect or out-of-date information obtained from IPF-related Internet resources. The objective of this study was to describe the characteristics of Internet resources available for IPF, and evaluate their readability, content (compared to established IPF guidelines), risk of bias, and overall quality.
Page 4 of 45

METHODS
Data sources and search strategy
We analyzed written online health information on IPF using the three most common Internet search engines. Google®, Yahoo®, and Bing® searches for 'idiopathic pulmonary fibrosis' were performed on June 29 th , 2015. Searches were performed using the United States (US) version for each search engine after removal of the web browsers' history and cookies. Country-specific results were standardized using a US Internet Protocol address to specify that searches were conducted in the US.
Study selection
The top 200 hits for each search engine were screened for eligibility criteria.
English websites intended to provide IPF information to patients or caregivers were eligible. One author (DOC) systematically determined website eligibility by reviewing the identified site and first-generation links to additional pages that remained within the original domain. A second author reviewed sites with unclear eligibility (CJR). Websites that required registration or enrolment fees to access information, duplicated websites, and scientific journal articles clearly intended for medical/research professionals were excluded.
Data extraction and website evaluation
Characteristics retrieved from each website included continent of origin, dates of publication and most recent update, and textual difficulty (measured using the Flesch Reading Ease Score [FRES] and the Flesch-Kincaid grade level). 8, 9 Websites were classified into 5 main categories, including scientific resources (e.g. academic
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Content varied across website categories (Figure 3) . The definition of IPF (a chronic scarring lung disease of unknown cause) was appropriately described in the majority of websites, but was more often incomplete in news/media sites compared to other categories (p=0.003; Supplementary Appendix Table E4 ). Significant differences were also observed between website categories in the symptoms, risk factors, diagnosis, and management of IPF, with scientific and foundation/advocacy sites generally performing better than news/media and personal commentary sites (Supplementary Appendix Table E4 and Table E5 ). The prognosis of IPF was adequately described in a minority of websites in all categories.
Oxygen and lung transplant were discussed in 57.5% and 63.5% of websites, respectively, and were more likely to be described in scientific and foundation websites ( Table 2) . Nintedanib, pirfenidone, anti-acid therapy, and palliative care were discussed in a minority of websites. Harmful and/or non-recommended treatments were frequently recommended, 6, 7 including azathioprine (15.5%), corticosteroids (38.7%), immunosuppressive therapy (14.4%), and n-acetylcysteine (18.2%). Azathioprine and corticosteroids were discussed as chronic treatments of IPF in 13.3% and 30.6% of the 98 websites that had been updated after publication of data demonstrating harm from these medications. 13 Foundation/advocacy organizations were most likely to suggest a role for these harmful and/or non-indicated therapies in IPF, while news/media reports were least likely (p=0.01 for azathioprine and p<0.0001 for corticosteroids; Table E6 ). Wikipedia (https://en.wikipedia.org/wiki/Idiopathic_pulmonary_fibrosis) provided the best balance between accurate IPF content and lack of inappropriate treatment recommendations.
Supplementary Appendix
Website content was only modestly estimated by potential predictor variables (Rsquared=0.27). Website category was the only independent predictor of content score, Table E7 ). Higher website rank within Yahoo® and Bing® was independently associated with more overall content in multivariate models constructed for each search engine.
Model performance for each search engine was not improved compared to the original multivariate model (R-squared≤0.27).
Website quality
The mean inter-observer agreement for individual DISCERN questions was 85%, with a mean kappa of 0.57. In general, websites scored poorly (mean score≤2) on questions that addressed treatment risks, what would happen without treatment, and the need for shared decision-making between patient and physician ( Figure 4 ). DISCERN total score was lower in news/media reports and personal commentary (blog) sites compared to other website categories (p=0.001; Higher website rank was independently associated with higher DISCERN total score in all search engines, with at most a modest improvement in model fit (R-squared≤0.28).
DISCUSSION
Patients with IPF frequently search the Internet for information related to their disease, however there are no previous studies evaluating the content, quality, or readability of these online resources. We applied multiple validated tools and standardized scoring systems to 181 IPF-related websites to demonstrate the overall poor content and quality of patient-directed Internet resources on the topic of IPF. These deficiencies have important implications in an era when patients are increasingly using the Internet to obtain health-related information.
We identified 25 content items that correspond to well established IPF features and therapies, however we were unable to determine a reliable method that predicted website accuracy. Many items were inadequately covered in all sites, including features that are highly relevant to IPF patients and caregivers such as details on diagnostic tests, Page 10 of 45 management, and prognosis. Scientific resources provided more content than other website categories, but were less likely to discuss recently approved antifibrotic therapies. News/media reports typically focused on a specific news item, including newly approved therapies, but were less likely to provide a general overview of IPF. Nearly half of all websites (48%) suggested a role for at least one unproven treatment, and more than a third of websites suggested a role for medications that were proven harmful in IPF over 3 years before our study was conducted. 13 Foundation and advocacy organizations were most likely to suggest these harmful and/or non-indicated therapies, despite patients likely considering these non-profit organizations a reliable source of information. This unpredictably inaccurate online information results in healthcare providers recommending different therapies than those that are discussed in reputable and reportedly up-to-date online sources, potentially leading to distrust of physicians that are providing appropriate and guideline-supported recommendations.
The impact of the frequently incomplete and inaccurate content is worsened by the poor reliability, quality, and readability that were observed all website categories.
These limitations are particularly challenging for a non-expert patient audience that is less able to assess the risk of bias in a specific website, and that has more difficulty incorporating that potential bias when assessing the reliability of that site's content.
Previous studies have applied the DISCERN and JAMA instruments to other diseases, suggesting the quality of online information on IPF is similar to breast cancer surgery, but worse than information available for prostate cancer. 14,15 According to the National Adult Literacy Survey, 43% of American adults have basic or below basic literacy (i.e.
can perform only simple literacy activities), 16 however IPF websites had a median reading grade level of 12 and a FRES score corresponding to a college student level.
The generally poor content, quality, and readability of IPF websites indicate the need for a reliable method for assessing which sites should be targeted by patients interested in learning more about IPF. Although content and quality were higher in scientific and foundation/advocacy sites compared to other website categories, overall scores for content and quality were low in all categories. HON is an internationally recognized independent organization that rates the quality of patient-directed online health information, however few IPF-related resources (15%) have HON certification and certification was associated with only modest improvements in website quality.
Importantly, incomplete and incorrect information was frequently provided in HON certified sites, sites from foundation and advocacy organizations, and sites that had been updated since publication of definitive evidence for or against specific IPF therapies. This highlights the challenges faced by patients and other non-experts when attempting to determine the accuracy of health information provided on the Internet.
Despite the variable quality, the Internet will remain a frequent resource for IPF patients given the easy access to information on virtually all health-related topics. The ongoing use of the Internet indicates the need for a strategy that attempts to increase the accuracy of online information, highlights and facilitates access to websites with appropriate content, and supports improvements of websites that contain misinformation.
At the time of our search, Wikipedia provided the best balance between content and quality, possibly due to the multi-author iterative approach to Wikipedia updates and site management, and similar approaches may be necessary to address the limitations of other common patient resources. The frequent deficiencies in most other websites suggest that IPF stakeholders need to take a more active role in ensuring the accuracy, quality, and readability of online health information.
In conclusion, this comprehensive and rigorous assessment of patient-directed online health information on IPF demonstrates that websites are frequently incomplete, inaccurate, and outdated, and that there is currently no reliable method for patients to identify sites that provide appropriate information. The low quality of online information on IPF is a significant barrier to patient education and higher standards are required for websites that are intended to provide IPF-related health information to patients with IPF.
Managers of all IPF-related websites should review website quality on a regular basis and ensure that provided content is consistent with guideline recommendations and recent advances in the medical literature. Eligibility criteria were sequentially applied in a mutually exclusive manner. Websites could be included in the results for multiple search engines. Each row represents an individual website. The shade of each cell represents the DISCERN score, ranging from a low score of 1 (white) to a high score of 5 (dark grey). The Content and DISCERN total scores were calculated for the top 10 websites retrieved in each search engine. 3  2  3  1  1  3  4  2  4   3  3  2  1  1  3  2  2  1  1  1  1  1  2  1  1   3  4  4  1  1  3  2  2  1  1  1  1  1  1  1  2   3  3  3  1  1  3  1  3  2  2  3  5  2  4  3  3   3  4  3  1  1  3  2  3  1  2  1  1  1  3  1  2   4  5  4  5  4  3  2  3  5  5  5  1  2  3  2  4   3  3  4  4  5  4  5  3  1  3  1  1  2  4  3  4   3  4  4  3  5  5  2  2  2  2  1  1  2  3  2  3   3  4  4  3  5  5  4  3  2  3  1  2  3  3  1  3   3  4  4  4  5  5  4  3  2  3  1  2  3  3  1  3   3  4  4  1  1  3  1  2  2  2  1  1  2  4  1  3   3  4  3  3  5  4  1  3  1  1  1  1  1  1  1  2   4  1  1  1  1  3  1  2  1  1  1  3  1  3  2  1   3  3  2  1  1  3  3  3  1  2  1  1  2  2  1  2   3  4  4  1  1  3  1  3  1  3  1  1  2  3  1  3   4  4  3  4  5  5  5  2  1  1  1  1  1  1  1  3   3  4  4  1  1  3  1  3  2  3  1  1  3  5  2  3   4  3  3  2  1  4  1  2  1  1  1  1  1  1  1  3   5  4  4  2  1  4  3  4  3  2  1  1  4  4  3  4   4  4  4  4  5  4  2  2  4  4  1  1  3  2  1  3   4  3  4  1  1  3  1  3  2  2  1  1  1  3  2  3   2  3  2  1  1  3  3  3  1  2  1  1  1  2  1  2   4  3  4  3  3  5  3  2  5  5  1  1  1  2  1  2   3  4  4  1  1  3  1  3  1  2  1  1  2  3  2  3   4  3  2  4  5  5  2  3  1  1  1  1  1  1  1  2   3  3  3  4  5  5  2  3  2  3  1  2  1  3  1  3   3  2  2  5  5  3  2  3  1  2  1  1  1  1  1  1   4  3  3  1  1  3  4  2  4  3  1  2  1  4  1  3   5  4  3  1  1  3  5  4  1  1  1  1  1  3  1  3   4  4  3  1  1  3  2  3  2  2  1  2  1  3  1  3   3  5  3  1  1  3  1  1  1  1  2  1  1  1  1  2 Foundation / Not-for-profit 4  4  5  2  3  4  5  3  4  5  4  1  3  5  4  4   3  3  3  3  3  4  3  3  2  3  1  1  1  3  2  3   3  4  4  2  2  4  4  2  5  4  2  2  2  5  4  3   4  4  4  1  4  4  3  4  3  3  3  1  2  4  5  3   3  4  4  5  5  5  5  2  2  5  1  1  3  4  1  4   5  5  5  4  5  5  5  4  3  3  2  2  3  5  5  5   4  4  3  2  1  2  4  2  1  4  2  1  3  2  5  3   4  4  4  1  1  4  3  2  3  3  2  1  5  5  3  3   3  4  4  1  1  3  4  4  2  3  2  2  3  3  3  3   2  2  3  1  1  4  5  4  1  2  1  1  1  4  4  3   4  5  5  2  1  4  2  4  4  4  4  2  5  5  5  4   4  1  2  5  5  3  2  1  1  1  1  1  1  1  1  1   3  4  4  1  1  3  5  2  1  1  1  1  1  1  1  2   4  4  4  3  1  5  2  3  2  2  3  2  4  3  3  3   4  5  5  1  1  4  5  4  4  5  3  3  4  5  4  4   4  4  4  5  5  5  5  3  3  3  1  3  3  5  1  4   3  3  2  1  1  2  2  2  2  2  1  1  1  1  2  2   4  4  3  1  1  3  1  3  1  1  1  2  1  3  1  2   2  2  2  1  1  3  1  1  1  2  1  1  3  1  3  2   4  4  4  1  1  4  1  3  3  4  1  1  1  4  1  3   3  3  4  1  1  3  1  2  2  2  1  1  1  3  1  3   4  3  3  1  1  3  1  3  1  1  1  1  1  1  1  2   4  4  5  5  5  5  4  4  5  5  1  1  2  4  1  4   3  2  2  1  1  3  2  2  2  2  1  1  1  2  1  2   4  3  4  3  1  5  3  3  4  4  3  1  1  3  2  4 For-profit 2  2  2  1  1  3  1  1  2  2  1  1  1  1  1  1   3  2  2  2  2  3  1  3  2  1  1  2  1  1  2  2   4  4  3  3  4  3  1  3  4  4  1  2  1  1  1  3   3  3  3  4  5  5  4  3  1  2  1  1  3  3  1  3   4  5  3  4  3  4  3  2  1  1  1  1  1  1  1  2   2  2  2  3  4  3  2  2  1  1  1  1  1  1  1  1   4  5  3  4  3  4  3  2  1  1  1  1  1  1  1  2   5  5  4  2  2  3  2  1  2  3  1  1  1  2  1  3   3  3  3  1  1  4  2  3  2  3  1  1  1  1  1  2   4  4  4  3  5  3  2  3  3  5  3  2  2  2  1  3   3  3  2  2  2  1  1  3  1  3  1  1  2  1  1  2   3  4  1  1  1  3  1  3  2  3  1  1  1  2  1  2   3  4  3  3  4  3  3  3  1  1  1  1  1  1  1  3   4  4  4  2  2  3  1  2  2  3  5  1  3  4  1  3   4  4  2  1  5  5  2  1  1  1  1  1  1  1  1  1   4  5  4  2  3  4  1  1  4  4  5  1  2  3  1  3   2  3  3  2  2  4  1  3  4  3  3  1  2  2  1  3   4  3  3  4  5  3  1  1  3  4  1  1  4  2  1  3   Independent blog   4  4  2  4  4  1  2  2  5  4  2  1  3  3  2  2   2  3  2  2  2  3  3  3  2  2  1  1  4  3  1  2   2  2  2  2  2  3  3  1  1  1  1  1  2  1  2  1   5  2  1  3  1  1  1  1  3  2  1  1  1  2  1  1   2  3  2  2  1  3  2  3  1  2  2  1  1  3  1  2   3  3  2  1  1  2  3  2  2  2  2  1  2  4  4  2   3  2  2  1  1  2  2  2  1  1  2  1  3  3  1  2   3  3  3  1  1  2  1  3  3  2  3  1  4  4  3  3   3  4  3  2  2  3  1  2  3  1  2  1  2  3  2  2   2  2  2  1  1  2  1  2  1  1  1  1  2  1  1  1   2  2  2  1  1  2  1  3  2  2  2  1  2  2  1  2   3  3  3  1  1  2  3  2  2  2  1  1  2  2  3  3   3  3  2  1  1  2  1  2  2  2  2  1  4  3  1  2   2  4  5  3  1  5  1  3  4  5  5  2  5  5  2  4   2  2  2  1  1  2  1  1  1  2  1  1  1  2  1  1   2  2  2  1  1  2  2  2  1  1  2  1  3  3  3  1   2  3  1  1  1  1  1  1  4  4  1  1  1  1  1  1   3  3  2  1  1  4  1  3  1  1  1  1  2  1  2  2   3  2  2  1  1  3  1  2  1  1  1  1  1  1  1  1   3  3  2  3  1  4  1  3  2  3  1  1  1  3  1  2   4  5  3  1  1  2  5  4  3  2  3  1  4  4  3  3   2  2  2  1  1  3  2  3  1  2  1  1  2  1 
TABLES
1 1 1 1 1 0 0 0 1 0 1 0 0 0 0 0 0 1 0 1 0 1 1 1 1 1 1 0 0 1 1 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0.5 1 1 1 1 1 1 0 0 1 0 1 1 0.5 0 1 0 0 0 0 1 1 1 1 0 0 1 1 1 1 1 1 1 0 1 0 0 0 0.5 0 1 0 0 0 1 1 1 1 1 1 0 1 1 1 1 1 0 0 1 1 0 1 1 1 0 1 1 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0.5 1 0 0 0 1 0 0 0 0 0 0 1 1 1 1 1 0 1 0 0 0 0.5 1 1 0 1 0 0 0 1 0 0 1 0 1 0 1 1 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 1 1 1 1 1 0 0 0.5 1 1 0.5 1 1 0 0 1 0 1 1 0 0.5 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 1 0 1 1 1 1 1 1 0 0 0 0 0 1 1 1 0 1 0 0 0 1 1 1 0 0 0 1 0 1 1 1 1 1 0 1 0 0.5 0 0.5 0.5 1 0 0 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 0.5 1 0.5 0.5 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 1 1 1 1 1 0.5 1 0 1 0 1 1 1 0 1 0 0 0 0 1 1 1 0 1 0 1 0 1 1 1 0 1 1 1 0 0.5 1 0.5 0.5 1 0 0 0 0 0 1 1 1 1 0 1 1 1 1 1 1 0 0 1 0 0 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0.5 0.5 1 0 0 0 0 0 0 1 0 1 0 1 1 1 1 1 1 0 1 1 0 0 0.5 1 0 1 0 0 0 1 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 1 0.5 1 1 0 0 0 1 1 1 1 0.5 1 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 0 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 0 0 1 1 1 1 0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 0 1 1 1 1 0 0 0 0 0 1 1 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 0 1 1 1 1 0 1 0 0 1 1 1 1 0 0 0 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 1 0 1 1 1 1 1 1 1 0 1 0 0 1 0 0 0 1 0 0 0 1 1 0 1 1 0 1 1 1 1 1 1 0 0 1 0 1 1 0.5 0.5 1 0 0 0 0 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 0 0 0.5 0.5 0 1 0 0 0 1 1 1 1 0 1 0 1 0 1 1 1 1 0 0 1 0 1 1 0.5 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 0 0 0 01 2 2 1 1 4 4 4 3 4 4 4 5 5 4 2 2 2 2 1 1 3 1 3 4 4 4 1 1 4 1 2 1 2 1 2 1 2 2 3 3 4 4 4 4 3 2 5 5 5 5 2 3 5 3 4 3 3 3 1 1 5 1 2 1 2 1 1 1 4 1 2 2 2 3 2 1 4 4 3 2 2 2 1 2 4 2 3 2 2 2 5 5 5 2 2 1 1 1 1 1 1 1 1 5 4 5 3 3 5 3 4 2 2 2 2 2 4 3 3 1 2 4 3 2 3 1 3 3 3 2 1 1 2 1 2 4 4 3 1 1 3 2 2 1 1 1 1 1 3 3 2 4 3 3 4 4 4 5 2 2 3 4 2 3 5 2 3 3 4 4 4 5 5 4 2 1 3 1 1 1 3 3 2 5 4 4 1 1 2 2 1 5 4 1 2 1 2 1 3 3 3 3 2 1 4 5 5 4 4 4 1 1 4 2 4 5 5 4 1 1 4 5 3 3 4 2 1 5 5 2 3 3 4 3 3 5 4 5 4 3 3 4 1 5 5 2 3 2 2 2 1 1 2 1 1 1 1 1 1 1 1 1 1 3 2 2 2 2 4 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 3 1 1 1 1 1 3 1 4 2 1 3 5 3 5 5 5 4 4 1 2 1 1 1 1 1 3 3 3 3 1 1 3 2 3 2 2 2 1 1 4 1 2 4 4 4 1 1 3 4 2 1 3 1 1 4 3 1 3 4 4 4 1 1 3 4 2 1 3 1 1 4 3 1 3 4 3 4 1 1 3 1 2 1 3 1 1 4 4 1 3 2 4 3 1 1 3 5 3 1 1 1 1 2 1 1 2 4 4 4 1 1 3 4 2 1 3 1 1 4 3 1 3 4 3 4 1 1 3 1 2 1 3 1 1 4 4 1 3 4 4 4 1 1 3 4 2 1 3 1 1 4 3 1 3 4 3 4 1 1 3 1 2 1 3 1 1 4 4 1 3 4 4 4 1 1 3 4 2 1 3 1 1 4 3 1 3 4 3 4 1 1 3 1 2 1 3 1 1 4 4 1 3 2 4 4 1 1 3 1 3 4 3 5 3 2 4 1 3 4 3 4 1 1 3 1 2 1 3 1 1 4 4 1 3 4 4 4 1 1 3 4 2 1 3 1 1 4 3 1 3 4 3 4 1 1 3 1 2 1 3 1 1 4 4 1 3 4 4 4 4 5 4 4 2 1 3 1 1 4 3 1 3 3 1 1 1 1 4 1 1 1 1 1 1 1 1 1 1 4 4 4 4 5 4 4 2 1 3 1 1 4 3 1 3 4 3 3 3 1 5 5 3 2 2 1 1 3 4 5 3 3 3 4 4 4 4 1 3 5 5 4 2 5 5 3 4 2 3 2 4 1 4 1 1 1 1 1 1 1 1 1 2 5 4 3 3 5 5 5 3 4 4 1 2 5 2 4 3 3 3 4 1 1 3 1 4 2 3 1 1 2 3 1 3 4 4 4 4 5 5 2 4 4 3 1 2 5 5 3 4 3 4 4 4 5 5 4
DISCERN scoring
DISCERN is a validated instrument designed to assess the quality of written information on treatment choices, and can be applied to any disease (Supplementary Appendix Table   E1 ). 3 Sixteen questions are rated from 1 (low quality/not addressed) through 5 (high quality/fully addressed). Questions 1-8 evaluate publication reliability, questions 9-15 evaluate the quality of information regarding treatment options, and question 16 evaluates the overall publication. DISCERN scores ≤2 were considered poor, 3 considered fair, and ≥4 considered good.
JAMA benchmarks
The JAMA benchmarks are 4 basic standards that should be met by Internet sources of medical information, 4 including: 1) Authorship: proper citations used in the website; 2)
Attribution: references and sources of information are identified; 3) Currency: the website is updated with the latest information; and 4) Disclosure: website ownership, advertising, and conflicts of interest are disclosed.
Statistical Methods
Date of last update was also specified a priori as a potentially relevant predictor variable, however this was excluded from the multivariate analysis since it was not reported in >20% of websites. Website rank within each search engine was tested for association with DISCERN and content scores in separate sensitivity analyses for each of the 3 search engines. Data are shown as mean +/-standard deviation. See Figure 3 and Table E2 for details of each content category. Kruskal-Wallis was used as a conservative test when determining significance between website categories, given the non-normality of some data. Wilcoxon rank sum testing was used as a conservative test when determining significance on pairwise testing given the non-normality of some data. Pairwise comparisons are not shown for Industry/For profit websites since these scores were between those of Scientific resources / Foundation/Advocacy organizations and Personal commentary / News/Media websites. 
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